HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Tag: covax-19
-
GOVERNMENT TO RESERVE 30 CRORE DOSES OF BIOLOGICAL E’S NEW VACCINE
Biological E, a Hyderabad-based vaccine and pharmaceutical company, has announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India called Corbevax…
-
NEW AUSTRALIAN COVID VACCINE TO COMPLETELY PREVENT COVID-19 TRANSMISSION
An Adelaide based company, Vaxine Pty Ltd has successfully developed a COVID vaccine, COVAX-19 that holds the ability to completely prevent the covid-19 virus transmission in non-immune individuals. No other…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila